Search for: "Global Pharmaceuticals, LLC" Results 41 - 60 of 267
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Oct 2009, 12:38 pm
Citigroup Global Market, Inc. has filed a motion to dismiss an action against it by KV Pharmaceuticals Co. arising out of sales of auction rate securities, according to an August 25 article in Law360 by Christine Caufield entitled "Citigroup Argues KV Pharma Knew ARS Risks. [read post]
17 Sep 2021, 11:35 am by Mark Astarita
The Securities Law Blog is a service of SECLaw.com, and Mark Astarita, a national securities lawyer with the law firm of Sallah Astarita & Cox, LLC [read post]
18 Jan 2010, 1:02 pm by Page Perry LLC
Two months ago we reported that Citigroup Global Markets, Inc. had asked a New York court to dismiss a $72 million lawsuit filed against it by KV Pharmaceutical Co. [read post]
18 Jan 2021, 6:02 am
Posted by Subodh Mishra, Institutional Shareholder Services, on Monday, January 18, 2021 Editor's Note: Jeff Lubitz is Executive Director at ISS Securities Class Action Services LLC. [read post]
5 Aug 2009, 5:35 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: US: America’s Affordable Health Choices Act : House Energy & Commerce Committee OKs 12-year data exclusivity for biotech drugs (Patent Baristas) (Patent Docs) (FDA Law Blog) (PatentlyBIOtech) (GenericsWeb)   General Pharmaceutical patent settlements under fire on both sides of the Atlantic… [read post]
11 Jan 2008, 9:00 am
: (Biotech Weblog),Immunomedics obtains antibody patent: (SmartBrief),Cyplasin Biomedical obtains US patent for protein based cancer treatment: (Patent Docs)Argatroban - Encysive Pharmaceuticals Inc., GlaxoSmithKline and Mitsubishi Chemical Corp. file patent infringement lawsuit to stop Barr Laboratories from producing a generic version of the anti-blood clotting drug: (IP Law360), Biaxin (Clarithromycin) - Court holds in Abbott Labs v Sandoz… [read post]
25 Nov 2019, 12:40 pm by Juvan Bonni
 Govind Persad: Examining Pharmaceutical Exceptionalism: Intellectual Property, Practical Expediency, and Global Health (Source: SSRN) Prof. [read post]
2 Jan 2014, 1:12 pm by Gene Quinn
” The judgment removes a major hurdle for Amneal Pharmaceuticals LLC, a U.S. [read post]
21 Jul 2021, 12:44 pm by Jon L. Gelman
The manufacturers named in the complaint included Purdue Pharma and its affiliates, as well as members of the Sackler Family (owners of Purdue) and trusts they control; Janssen Pharmaceuticals and its affiliates (including its parent company Johnson & Johnson); Mallinckrodt LLC and its affiliates; Endo Health Solutions and its affiliates; Teva Pharmaceuticals USA, Inc. and its affiliates; and Allergan Finance, LLC and its affiliates. [read post]
16 Jun 2010, 3:02 pm
Stamatios Mouratidis (TTABlog) US: Multiple rejections during prosecution undermine plaintiff’s bid for preliminary injunction: Graceway Pharmaceuticals, LLC et al v. [read post]
1 May 2009, 9:00 am
(IAM) US: Johnson & Johnson – 5 year exclusivity period would kill incentives to innovate (Patent Docs) US: CHI CEO on patent reform and follow-on biologics legislation (Patent Docs) US: BIO urges Congress on patent reform: First, do no harm (Patent Baristas) US: Pharmaceutical advertising: How to use a domain name to circumvent application of law (Domain Name / Nom De Domaine!) [read post]
4 Apr 2008, 1:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Heirs of Superman’s creator Jerome Siegel win share of copyright with Time Warner: (IP Law360), (IPKat), (Public Knowledge), Delhi High Court recognizes, for the first time in India, the need to consider public interest in allowing or rejecting an order of injunction: (Indian Patent Oppositions), (Generic… [read post]
16 Sep 2010, 2:00 am by Duncan
To claim your discount, just click this link (Pharmaceutical, Biotechnology and Chemical Inventions) and enter the code ‘ALBUCK10? [read post]
22 May 2012, 6:30 am by Rebecca Tushnet
In the Matter of POM Wonderful LLC and Roll Global LLC, FTC File No. 082-3122 (May 21, 2012) Bottom line: while rejecting complaint counsel’s arguments that double-blind, randomized clinical trials were required to substantiate health claims of the sort made by Pom, the ALJ found that Pom didn’t meet the somewhat lower standard of reliable and competent scientific evidence either with respect to claims about heart health/disease, prostate health/disease,… [read post]
29 Feb 2008, 8:00 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included:German Federal Constitutional Court: unauthorised government surveillance of personal computers breaches individual’s right to privacy: (Catch Us If You Can!!!) [read post]
16 Nov 2009, 4:51 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Putting the USPTO to work for independent inventors (Director's Forum) (Inventive Step) (IP Asset Maximizer Blog) (Patently-O) Tafas v Kappos - CAFC dismisses Tafas suit against Rules; leaves lower court ruling in tact (Patent Baristas) (Patently-O) (Patent Docs) (America-Israel Patent Law) Global Global - General… [read post]
16 Nov 2009, 4:51 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Putting the USPTO to work for independent inventors (Director's Forum) (Inventive Step) (IP Asset Maximizer Blog) (Patently-O) Tafas v Kappos - CAFC dismisses Tafas suit against Rules; leaves lower court ruling in tact (Patent Baristas) (Patently-O) (Patent Docs) (America-Israel Patent Law) Global Global - General… [read post]